Table of Contents
Volume 7 | Issue 6
Publication Date: May 2006- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
369-370 |
Smoking History: Tumor Biology and Clinical Pharmacokinetic Implications in Patients with Lung Cancer Shirish M. Gadgeel |
|
Meeting Highlight | ||
373-377 |
Highlights From: 97th Annual Meeting of the American Association for Cancer Research, Washington, DC, April 2006 Aarati Ranganathan, Alfredo Budillon, Primo Lara, Jr |
|
Mini-Reviews | ||
381-384 |
Clinical Development of Src Tyrosine Kinase Inhibitors in Lung Cancer David Lee, Oliver Gautschi |
|
385-388 |
Pharmacodynamic Separation of Epidermal Growth Chemotherapy in Non–Small-Cell Lung Cancer Angela M. Davies, Cheryl Ho, Primo N. Lara, Jr, Philip Mack, Paul H. Gumerlock, David R. Gandara |
|
Original Contributions | ||
389-394 |
Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21 Gary M. Clark, Denni M. Zborowski, Pedro Santabárbara, Keyue Ding, Marlo Whitehead, Lesley Seymour, Frances A. Shepherd |
|
395-400 |
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non–Small-Cell Lung Cancer Paulo Ghio, Susanna Cappia, Giovanni Selvaggi, Sylvia Novello, Paulo Lausi, Gabriella Zecchina, Marno Papotti, Piero Borasio, Giorgio V. Scagliotti |
|
401-405 |
Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non–Small-Cell Lung Cancer Carmelo Tibaldi, Ilaria Bernardini, Antonio Chella, Francesa Russo, Enrico Vasile, Michele Malventi, Alfredo Falcone |
|
406-411 |
Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non–Small-Cell Lung Cancer Martin Reck, Erika Buchholz, Kathrin Schott-von-Römer, Katrin Krützfeldt, Ulrich Gatzemeier, Christian Manegold |
|
412-416 |
Decreased Fragile Histidine Triad Gene Messenger RNA Expression in Lung Cancer Hidefumi Sasaki, Hiroshi Haneda, Haruhiro Yukiue, Yoshihiro Kobayashi, Motoki Yano, Yoshitaka Fujii |
|
Current Trial | ||
417-419 |
PIONEER: A Phase III Randomized Trial of Paclitaxel Poliglumex Versus Paclitaxel in Chemotherapy-Naive Women with Advanced-Stage Non–Small-Cell Lung Cancer and Performance Status of 2 Kathy S. Albain, Chandra P. Belani, Philip Bonomi, Kenneth J. O’Byrne, Joan H. Schiller, Mark Socinski |
|
Clinical Trials | ||
420 |
Selected Clinical Trials in Lung Cancer CIG Media Group |
|